Lipanthyl NT 145 mg/Lipanthyl Supra 160 mg/Lipanthyl 67 mg Indications/Uses

Hypercholesterolemia and hypertriglyceridemia alone or combined (types IIa, IIb, IV dyslipidemias, as well as types III and V dyslipidemias) in patients unresponsive to dietary and other non-drug therapeutic measures (e.g. weight reduction or increased physical activity), particularly when there is evidence of associated risk such as hypertension and smoking.
The treatment of secondary hyperlipoproteinemias is indicated if the hyperlipoproteinemia persists despite effective treatment of the underlying disease (e.g. dyslipidemia in diabetes mellitus).
Appropriate dietary measures initiated before therapy should be continued.
Lipanthyl NT 145 mg: Additional indication: Fenofibrate (Lipanthyl NT) 145 mg is indicated for the reduction in the progression of diabetic retinopathy in patients with type 2 diabetes and existing diabetic retinopathy. Fenofibrate (Lipanthyl NT) 145 mg does not replace the appropriate control of blood pressure, blood glucose and blood lipids in reducing the progression of diabetic retinopathy.